Innovative Technology Flosonics Medical's FloPatch is a groundbreaking wearable ultrasound device designed for real-time hemodynamic monitoring, suitable for both hospital and out-of-hospital settings, opening opportunities to expand sales within critical care and home health markets.

Recent Clinical Validation The publication of the SaFER protocol and peer-reviewed studies position FloPatch as a validated, practical solution for fluid management, which can enhance credibility and adoption efforts among healthcare providers seeking evidence-based tools.

Strong Financial backing With recent venture debt investments of over 7.5 million CAD and a Series C funding round of 20 million USD, Flosonics has solid financial support, enabling scaling efforts and outreach to expanding healthcare systems and early adopters.

Award Recognition Receiving multiple industry awards, including Best in Class Digital Health, boosts market visibility and positions FloPatch as a trusted, innovative leader in digital diagnostics, which can facilitate introductions to new hospital systems and diagnostic providers.

Expanding Market Presence Based in Canada with offices in Sudbury and Toronto and active publication and funding efforts, Flosonics is strategically positioned to penetrate North American markets and build partnerships with healthcare institutions seeking advanced critical care solutions.